421 related articles for article (PubMed ID: 23396072)
1. Clinicopathologic study of pineal parenchymal tumors of intermediate differentiation.
Ito T; Kanno H; Sato K; Oikawa M; Ozaki Y; Nakamura H; Terasaka S; Kobayashi H; Houkin K; Hatanaka K; Murata J; Tanaka S
World Neurosurg; 2014; 81(5-6):783-9. PubMed ID: 23396072
[TBL] [Abstract][Full Text] [Related]
2. [Pineal Parenchymal Tumor with Marked Cytologic Pleomorphism: Is there a Correlation with the Malignancy Grade?].
Ito T; Sato K; Ozaki Y; Asanome T; Nakamura H; Tanaka S; Kimura T; Kanno H
No Shinkei Geka; 2016 Jun; 44(6):481-7. PubMed ID: 27270146
[TBL] [Abstract][Full Text] [Related]
3. Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome.
Raleigh DR; Solomon DA; Lloyd SA; Lazar A; Garcia MA; Sneed PK; Clarke JL; McDermott MW; Berger MS; Tihan T; Haas-Kogan DA
Neuro Oncol; 2017 Jan; 19(1):78-88. PubMed ID: 27282397
[TBL] [Abstract][Full Text] [Related]
4. Expression of O⁶-methylguanine DNA methyltransferase (MGMT) and immunohistochemical analysis of 12 pineal parenchymal tumors.
Kanno H; Nishihara H; Oikawa M; Ozaki Y; Murata J; Sawamura Y; Kato M; Kubota K; Tanino M; Kimura T; Nagashima K; Itoh T; Tanaka S
Neuropathology; 2012 Dec; 32(6):647-53. PubMed ID: 22458700
[TBL] [Abstract][Full Text] [Related]
5. Utility of Ki67 immunostaining in the grading of pineal parenchymal tumours: a multicentre study.
Fèvre-Montange M; Vasiljevic A; Frappaz D; Champier J; Szathmari A; Aubriot Lorton MH; Chapon F; Coulon A; Quintin Roué I; Delisle MB; Figarella-Branger D; Laquerrière A; Miquel C; Michiels JF; Péoch M; Polivka M; Fauchon F; Jouvet A
Neuropathol Appl Neurobiol; 2012 Feb; 38(1):87-94. PubMed ID: 21696422
[TBL] [Abstract][Full Text] [Related]
6. Pineal parenchymal tumours and pineal cysts.
Jouvet A; Vasiljevic A; Champier J; Fèvre Montange M
Neurochirurgie; 2015; 61(2-3):123-9. PubMed ID: 24975206
[TBL] [Abstract][Full Text] [Related]
7. Primary pineal tumors - Unraveling histological challenges and certain clinical myths.
Verma A; Epari S; Bakiratharajan D; Sahay A; Goel N; Chinnaswamy G; Shetty P; Moiyadi A; Goel A; Gupta T; Jalali R
Neurol India; 2019; 67(2):491-502. PubMed ID: 31085866
[TBL] [Abstract][Full Text] [Related]
8. Pineal parenchymal tumours of intermediate differentiation - An evidence-based review of a new pathological entity.
Amato-Watkins AC; Lammie A; Hayhurst C; Leach P
Br J Neurosurg; 2016; 30(1):11-5. PubMed ID: 26571134
[TBL] [Abstract][Full Text] [Related]
9. Long term outcome of adolescent and adult patients with pineal parenchymal tumors treated with fractionated radiotherapy between 1982 and 2003--a single institution's experience.
Stoiber EM; Schaible B; Herfarth K; Schulz-Ertner D; Huber PE; Debus J; Oertel S
Radiat Oncol; 2010 Dec; 5():122. PubMed ID: 21184689
[TBL] [Abstract][Full Text] [Related]
10. Histopathology of tumors of the pineal region.
Fèvre-Montange M; Vasiljevic A; Champier J; Jouvet A
Future Oncol; 2010 May; 6(5):791-809. PubMed ID: 20465391
[TBL] [Abstract][Full Text] [Related]
11. Clinical Features of Pineal Parenchymal Tumors of Intermediate Differentiation (PPTID): A Single-Institution Series.
Kunigelis KE; Kleinschmidt-DeMasters BK; Youssef AS; Lillehei KO; Ormond DR
World Neurosurg; 2021 Nov; 155():e229-e235. PubMed ID: 34418607
[TBL] [Abstract][Full Text] [Related]
12. Pineal parenchymal tumors--utility of immunohistochemical markers in prognostication.
Arivazhagan A; Anandh B; Santosh V; Chandramouli BA
Clin Neuropathol; 2008; 27(5):325-33. PubMed ID: 18808064
[TBL] [Abstract][Full Text] [Related]
13. Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study.
Liu APY; Li BK; Pfaff E; Gudenas B; Vasiljevic A; Orr BA; Dufour C; Snuderl M; Karajannis MA; Rosenblum MK; Hwang EI; Ng HK; Hansford JR; Szathmari A; Faure-Conter C; Merchant TE; Levine M; Bouvier N; von Hoff K; Mynarek M; Rutkowski S; Sahm F; Kool M; Hawkins C; Onar-Thomas A; Robinson GW; Gajjar A; Pfister SM; Bouffet E; Northcott PA; Jones DTW; Huang A
Acta Neuropathol; 2021 May; 141(5):771-785. PubMed ID: 33619588
[TBL] [Abstract][Full Text] [Related]
14. CD24 and PRAME Are Novel Grading and Prognostic Indicators for Pineal Parenchymal Tumors of Intermediate Differentiation.
Wu X; Wang W; Lai X; Zhou Y; Zhou X; Li J; Liang Y; Zhu X; Ren X; Ding Y; Liang L
Am J Surg Pathol; 2020 Jan; 44(1):11-20. PubMed ID: 31567202
[TBL] [Abstract][Full Text] [Related]
15. Prognosticating survival of pineal parenchymal tumors of intermediate differentiation (PPTID) by grade.
Lu VM; Luther EM; Eichberg DG; Morell AA; Shah AH; Komotar RJ; Ivan ME
J Neurooncol; 2021 Nov; 155(2):165-172. PubMed ID: 34606044
[TBL] [Abstract][Full Text] [Related]
16. Pineal parenchymal tumor of intermediate differentiation showing malignant progression at relapse.
Kim BS; Kim DK; Park SH
Neuropathology; 2009 Oct; 29(5):602-8. PubMed ID: 19170892
[TBL] [Abstract][Full Text] [Related]
17. Integrated Genomic Characterization of a Pineal Parenchymal Tumor of Intermediate Differentiation.
Kang YJ; Bi WL; Dubuc AM; Martineau L; Ligon AH; Berkowitz AL; Aizer AA; Lee EQ; Ligon KL; Ramkissoon SH; Dunn IF
World Neurosurg; 2016 Jan; 85():96-105. PubMed ID: 26226092
[TBL] [Abstract][Full Text] [Related]
18. Management paradigms along a histologic spectrum of pineal cell tumors.
Sonabend AM; Bruce JN
World Neurosurg; 2014; 81(5-6):685-7. PubMed ID: 23928426
[No Abstract] [Full Text] [Related]
19. [Pathological and immunohistochemical study of pineal parenchymal tumors].
Fang J; Luo L; Li J; Sun S; Yuan Y
Zhonghua Bing Li Xue Za Zhi; 2002 Feb; 31(1):8-11. PubMed ID: 11955327
[TBL] [Abstract][Full Text] [Related]
20. Pineal Parenchymal Tumors of Intermediate Differentiation: A long-Term Follow-Up Study in Helsinki Neurosurgery.
Choque-Velasquez J; Resendiz-Nieves JC; Jahromi BR; Colasanti R; Raj R; Tynninen O; Collan J; Hernesniemi J
World Neurosurg; 2019 Feb; 122():e729-e739. PubMed ID: 30391615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
